Global Nanomedicine Market (2023-2028) by Indication, Drug Delivery System, Product, Application, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Global Nanomedicine Market (2023-2028) by Indication, Drug Delivery System, Product, Application, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis


The Global Nanomedicine Market is estimated to be USD 227.64 Bn in 2023 and is expected to reach USD 422.38 Bn by 2028 growing at a CAGR of 13.16%.
The use of nanotechnology in medicine and healthcare is referred to as nanomedicine. It includes the use of nanoscale materials for diagnostic, therapeutic, and preventive reasons, such as nanoparticles, nanocapsules, or nanofibers. Nanotechnology concerns structures and materials on the nanometer scale, which ranges from 1 to 100 nanometers.
The rising frequency of chronic and infectious diseases has accelerated the development of nanomedicine. These diseases provide important therapeutic and management issues, and nanomedicine offers novel answers. Nanotechnology-based drug delivery systems have the potential to improve therapeutic efficacy, improve targeted distribution to impacted areas, and lessen side effects. With the increasing global burden of such diseases, the demand for more advanced and efficient therapeutic techniques is driving the development and implementation of nanomedicine.
Nanomedicine has transformed drug administration by introducing novel drug delivery strategies that improve patient outcomes. Drugs can be enclosed by nanoparticles, allowing for targeted delivery to specific cells or tissues, improving medication efficacy, and reducing systemic toxicity. This method has the potential to change the therapeutic landscape for a variety of disorders. Furthermore, governments are recognizing the potential of nanomedicine and providing support and financing for research and development in this field, speeding up its advancement and commercialization.
The widespread use of novel technologies is a fundamental driver of nanomedicine. Nanotechnology provides unique and sophisticated capabilities such as exact nanoscale manipulation and control, surface alterations, and multifunctional features. These technologies allow for the creation of nanoscale materials and devices with improved performance and functionality for medical applications. The possibility of enhanced diagnostics, targeted therapies, and regenerative medicine has fueled academics', clinicians', and healthcare companies' interest and acceptance of nanomedicine, resulting in continual developments in the field.
The growing demand for medicines with fewer side effects opens up new opportunities for nanomedicine. Nanotechnology-based drug delivery systems can improve therapeutic medication delivery by limiting the impact on healthy tissues and minimizing negative effects. This opens up new avenues for generating more bearable and safer medicines for patients. Furthermore, nanomedicine can potentially increase therapy cost-effectiveness by optimizing medication dosages, reducing the need for frequent dosing, and improving treatment outcomes, lowering overall healthcare expenditures.
Nanodrug licensing and the expansion of healthcare facilities in emerging economies present considerable potential for nanomedicine. Emerging economies are investing in modern medical technologies and expanding their healthcare infrastructure. This fosters an atmosphere conducive to the acceptance and commercialization of nanomedicine products. Out-licensing nanodrugs enables Corps to collaborate with local manufacturers or distributors, allowing for a broader market reach and easier access to these novel therapeutics in emerging regions. This represents a significant growth and market expansion opportunity in the field of nanomedicine.
The high cost of therapy using nanomedicines is one market limitation in the field of nanomedicine. Nanomedicine development, manufacture, and regulatory approval processes can be complex and costly. Furthermore, the usage of specialized equipment and materials increases the overall cost. These issues, particularly in resource-constrained healthcare systems, can limit patient access to and acceptance of nanomedicine therapy.
The lengthy clearance procedure and accompanying hazards are one commercial hurdle in nanomedicine. Nanomedicine regulatory pathways can be complex and time-consuming, requiring comprehensive preclinical and clinical testing to assure safety and efficacy. Furthermore, there may be questions about the long-term impacts and potential hazards of using nanomaterials in medical applications. These problems can make it difficult to bring nanomedicine products to market efficiently and on time.

Market Segmentations

The Global Nanomedicine Market is segmented based on Indication, Drug Delivery System, Product, Application, and Geography.
By Indication, the Global Nanomedicine Market is classified into Cardiovascular Diseases, Immunological Diseases, Infectious Diseases, Neurological Diseases, Oncological Diseases, Ophthalmological Diseases, Orthopedic Disorders, and Urological Diseases.
Oncological diseases have a larger market share in the field of nanomedicine. This is primarily due to the increased incidence and prevalence of cancer worldwide and the growing desire for specialized therapies and personalized medicine. Nanomedicine offers promising cancer treatment options such as customized drug delivery, imaging agents, and therapeutic nanoparticles.
By Drug Delivery System, the Global Nanomedicine Market is classified into Carbon Nanotube, Dendrimers, Exosomes, Graphene, Injectable Nanoparticle Generator, Liposomes, Nanobubbles, Nanoclusters, and Nanoghosts.
Liposomes hold a larger market share. This is because liposomes have undergone significant research and have well-established safety and efficacy profiles. They are versatile in terms of drug encapsulation and have demonstrated effectiveness in delivering therapeutic substances to specific areas.
By Product, the Global Nanomedicine Market is classified into In-vitro Diagnostics, In-vivo Diagnostics, Regenerative Medicine, Therapeutics, and Vaccines.
Therapeutics hold a significant market share. This is because therapies include a wide range of applications, such as specific drug delivery systems, nanocarriers, and nanotherapeutics. The demand for new and effective therapies for a variety of diseases has driven this market.
By Application, the Global Nanomedicine Market is classified into Anti-Infectives, Anti-Inflammatory, Cardiovascular, and Neurology.
Cardiovascular holds a larger market share. This is largely due to the global prevalence of cardiovascular disorders like heart disease and stroke. Nanomedicine holds the promise of targeted drug delivery systems and diagnostic imaging agents.
By Geography, the Global Nanomedicine Market is classified into the Americas, Europe, Middle-East & Africa, and Asia-Pacific.
The Americas hold a significant market share in the Global Nanomedicine Market. This is due to the region's well-established healthcare infrastructure, excellent R&D capabilities, and major investment in nanotechnology. The presence of significant pharmaceutical and biotechnology companies also adds to the Americas' bigger market share.

Recent Development

Nanoparticles to aid cancer treatments – November 2022
The EU-funded SAFE-N-MEDTECH project is creating an open access platform to foster the development of next-generation nanotechnology-based medical devices. – June 2022

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Arrowhead Pharmaceuticals, Inc, Celgene Corp., Nanobiotix SA, Sanofi SA, etc.

Countries Studied

America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
Europe (Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxemburg, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
Middle-East and Africa (Egypt, Israel, Qatar, Nigeria, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

IGR Competitive Quadrant

The report includes IGR Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Nanomedicine Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development, and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
Infogence Global Research analyses the Global Nanomedicine Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
Based on the SWOT analysis conducted on the industry and industry players, Infogence Global Research has devised suitable strategies for market growth.

Why buy this report?

•The report offers a comprehensive evaluation of the Global Nanomedicine Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
•The research report also provides a detailed market size analysis and projections in volume and value terms. The projections are calculated using verified research methodologies.
•Excel data sheet for the market size will also be provided with the report.
•The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
•The report includes an in-depth market analysis using Porter’s 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
•The report includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
•The report includes Self-Assessment Form, which helps customers evaluate their position in the market compared to their competitors
•The report offers customized research - tailored uniquely to our customers with a quick turnaround time. We offer a 15% customization option at no extra charge to all our clients for any of our syndicated reports.

Report Highlights
•A complete analysis of the market, including the parent industry
•Important market dynamics and trends
•Impact Analysis – a comprehensive assessment to confront risk and make strategic & operational decisions to counter the changes in the market environment.
•Market segmentation
•Competitive Analysis: Comparative analysis of competitor
•Historical, current, and projected size of the market based on value and volume
•Market size of the US states
•Market shares and strategies of key players
•Recommendations to companies for strengthening their foothold in the market

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research0
2.2.3 IGR Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Impact Analysis
4.2 Drivers
4.2.1 Increasing Prevalence of Chronic and Infectious Diseases
4.2.2 Significantly Revolutionized Drug Administration and Increase in Government Support & Funding
4.2.3 High Adoption of Innovative Technologies
4.3 Restraints
4.3.1 High Cost of Treatment Using Nanomedicines
4.4 Opportunities
4.4.1 Increasing Need for Therapies with Fewer Side Effects, and Cost-Effectiveness of Therapies
4.4.2 Increasing Out-Licensing of Nanodrugs and Growth of Healthcare Facilities in Emerging Economies
4.5 Challenges
4.5.1 Long Approval Process and Risks Associated with Nanomedicine
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 PESTLE Analysis
5.4 Impact of COVID-19
5.5 Ansoff Matrix Analysis
6 Global Nanomedicine Market, By Indication
6.1 Introduction
6.2 Cardiovascular Diseases
6.3 Immunological Diseases
6.4 Infectious Diseases
6.5 Neurological Diseases
6.6 Oncological Diseases
6.7 Ophthalmological Diseases
6.8 Orthopedic Disorders
6.9 Urological Diseases
7 Global Nanomedicine Market, By Drug Delivery System
7.1 Introduction
7.2 Carbon Nanotube
7.3 Dendrimers
7.4 Exosomes
7.5 Graphene
7.6 Injectable Nanoparticle Generator
7.7 Liposomes
7.8 Nanobubbles
7.9 Nanoclusters
7.10 Nanoghosts
8 Global Nanomedicine Market, By Product
8.1 Introduction
8.2 In-vitro Diagnostics
8.3 In-vivo Diagnostics
8.4 Regenerative Medicine
8.5 Therapeutics
8.6 Vaccines
9 Global Nanomedicine Market, By Application
9.1 Introduction
9.2 Anti-Infectives
9.3 Anti-Inflammatory
9.4 Cardiovascular
9.5 Neurology
10 America’s Nanomedicine Market
10.1 Introduction
10.2 Argentina
10.3 Brazil
10.4 Canada
10.5 Chile
10.6 Colombia
10.7 Mexico
10.8 Peru
10.9 United States
10.10 Rest of Americas
11 Europe's Nanomedicine Market
11.1 Introduction
11.2 Austria
11.3 Belgium
11.4 Denmark
11.5 Finland
11.6 France
11.7 Germany
11.8 Ireland
11.9 Italy
11.10 Luxembourg
11.11 Netherlands
11.12 Norway
11.13 Poland
11.14 Russia
11.15 Spain
11.16 Sweden
11.17 Switzerland
11.18 United Kingdom
11.19 Rest of Europe
12 Middle East and Africa's Nanomedicine Market
12.1 Introduction
12.2 Egypt
12.3 Israel
12.4 Qatar
12.5 Nigeria
12.6 Saudi Arabia
12.7 South Africa
12.8 United Arab Emirates
12.9 Rest of MEA
13 APAC's Nanomedicine Market
13.1 Introduction
13.2 Australia
13.3 Bangladesh
13.4 China
13.5 India
13.6 Indonesia
13.7 Japan
13.8 Malaysia
13.9 Philippines
13.10 Singapore
13.11 South Korea
13.12 Sri Lanka
13.13 Thailand
13.14 Taiwan
13.15 Rest of Asia-Pacific
14 Competitive Landscape
14.1 IGR Competitive Quadrant
14.2 Market Share Analysis
15 Company Profiles
15.1 Abbott Laboratories
15.1.1 Company Overview
15.1.2 Company Snapshot
15.1.3 Product Overview
15.1.4 Business Overview
15.1.5 SWOT Analysis
15.1.6 Recent Developments
15.2 Arrowhead Pharmaceuticals, Inc
15.2.1 Company Overview
15.2.2 Company Snapshot
15.2.3 Product Overview
15.2.4 Business Overview
15.2.5 SWOT Analysis
15.2.6 Recent Developments
15.3 AstraZeneca
15.3.1 Company Overview
15.3.2 Company Snapshot
15.3.3 Product Overview
15.3.4 Business Overview
15.3.5 SWOT Analysis
15.3.6 Recent Developments
15.4 Bio-gate
15.4.1 Company Overview
15.4.2 Company Snapshot
15.4.3 Product Overview
15.4.4 Business Overview
15.4.5 SWOT Analysis
15.4.6 Recent Developments
15.5 Celgene
15.5.1 Company Overview
15.5.2 Company Snapshot
15.5.3 Product Overview
15.5.4 Business Overview
15.5.5 SWOT Analysis
15.5.6 Recent Developments
15.6 Celgene Corp.
15.6.1 Company Overview
15.6.2 Company Snapshot
15.6.3 Product Overview
15.6.4 Business Overview
15.6.5 SWOT Analysis
15.6.6 Recent Developments
15.7 GE Company
15.7.1 Company Overview
15.7.2 Company Snapshot
15.7.3 Product Overview
15.7.4 Business Overview
15.7.5 SWOT Analysis
15.7.6 Recent Developments
15.8 Johnson & Johnson
15.8.1 Company Overview
15.8.2 Company Snapshot
15.8.3 Product Overview
15.8.4 Business Overview
15.8.5 SWOT Analysis
15.8.6 Recent Developments
15.9 Luminex
15.9.1 Company Overview
15.9.2 Company Snapshot
15.9.3 Product Overview
15.9.4 Business Overview
15.9.5 SWOT Analysis
15.9.6 Recent Developments
15.10 Merck & Co., Inc.
15.10.1 Company Overview
15.10.2 Company Snapshot
15.10.3 Product Overview
15.10.4 Business Overview
15.10.5 SWOT Analysis
15.10.6 Recent Developments
15.11 Nanobiotix SA
15.11.1 Company Overview
15.11.2 Company Snapshot
15.11.3 Product Overview
15.11.4 Business Overview
15.11.5 SWOT Analysis
15.11.6 Recent Developments
15.12 Nanospectra Biosciences, Inc.
15.12.1 Company Overview
15.12.2 Company Snapshot
15.12.3 Product Overview
15.12.4 Business Overview
15.12.5 SWOT Analysis
15.12.6 Recent Developments
15.13 NanoString Technologies, Inc.
15.13.1 Company Overview
15.13.2 Company Snapshot
15.13.3 Product Overview
15.13.4 Business Overview
15.13.5 SWOT Analysis
15.13.6 Recent Developments
15.14 Nanoviricides
15.14.1 Company Overview
15.14.2 Company Snapshot
15.14.3 Product Overview
15.14.4 Business Overview
15.14.5 SWOT Analysis
15.14.6 Recent Developments
15.15 Novartis International AG
15.15.1 Company Overview
15.15.2 Company Snapshot
15.15.3 Product Overview
15.15.4 Business Overview
15.15.5 SWOT Analysis
15.15.6 Recent Developments
15.16 Pfizer Inc.
15.16.1 Company Overview
15.16.2 Company Snapshot
15.16.3 Product Overview
15.16.4 Business Overview
15.16.5 SWOT Analysis
15.16.6 Recent Developments
15.17 Roche Holding AG
15.17.1 Company Overview
15.17.2 Company Snapshot
15.17.3 Product Overview
15.17.4 Business Overview
15.17.5 SWOT Analysis
15.17.6 Recent Developments
15.18 Sanofi SA
15.18.1 Company Overview
15.18.2 Company Snapshot
15.18.3 Product Overview
15.18.4 Business Overview
15.18.5 SWOT Analysis
15.18.6 Recent Developments
15.19 Takeda Pharmaceutical Co. Ltd.
15.19.1 Company Overview
15.19.2 Company Snapshot
15.19.3 Product Overview
15.19.4 Business Overview
15.19.5 SWOT Analysis
15.19.6 Recent Developments
15.20 Teva Pharmaceutical
15.20.1 Company Overview
15.20.2 Company Snapshot
15.20.3 Product Overview
15.20.4 Business Overview
15.20.5 SWOT Analysis
15.20.6 Recent Developments
16 Appendix
16.1 Self-Assessment Form

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings